Data is not available at this time.
Jiangsu Yangnong Chemical Co., Ltd. operates as a specialized agrochemical producer within China's basic materials sector, focusing primarily on the development, manufacturing, and distribution of pyrethroid-based pesticides. Its core revenue model is built on selling these chemical products for both agricultural applications, which protect crops from pests, and public health uses, such as mosquito control, serving a critical need in food security and disease prevention. The company has established a significant domestic footprint while also extending its market reach through exports, leveraging its integrated production capabilities and technical expertise in synthetic pyrethroids. Positioned as a key player in the agricultural inputs industry, Yangnong Chemical benefits from the essential nature of its products, though it operates in a competitive and regulated market that demands continuous innovation and strict compliance with environmental and safety standards.
The company reported robust revenue of CNY 10.43 billion for the period, demonstrating strong market demand for its pesticide products. Net income reached CNY 1.20 billion, reflecting effective cost management and operational efficiency. Healthy operating cash flow of CNY 2.16 billion supports ongoing business activities and strategic investments, indicating solid cash generation from core operations.
Yangnong Chemical exhibits considerable earnings power with a diluted EPS of CNY 2.98. The significant positive operating cash flow, substantially exceeding net income, highlights strong quality of earnings and efficient conversion of profits into cash. Capital expenditures of CNY 1.84 billion indicate active investment in maintaining and potentially expanding production capacity.
The company maintains a conservative financial structure with cash and equivalents of CNY 1.62 billion providing ample liquidity. Total debt of CNY 1.19 billion appears manageable relative to its cash position and earnings capacity, suggesting a low-risk balance sheet. This financial stability supports operational flexibility and resilience against market fluctuations.
The company demonstrates a shareholder-friendly approach through its dividend distribution of CNY 0.68 per share. While specific growth rates are not provided, the substantial revenue base and profitability indicate a mature yet stable operation. The balance between reinvestment through capital expenditures and returning capital to shareholders suggests a balanced growth and income strategy.
With a market capitalization of approximately CNY 29.72 billion, the market values the company at a multiple that reflects its position in the essential agricultural inputs sector. A beta of 0.991 indicates stock volatility closely aligned with the broader market, suggesting investors view it as a relatively stable investment within its sector despite cyclical agricultural demand patterns.
Yangnong Chemical's strategic advantage lies in its specialization in pyrethroids, essential products for crop protection and public health. Its integrated manufacturing and established market presence provide competitive moats. The outlook remains tied to global agricultural demand, regulatory environments, and the company's ability to maintain production efficiency and product efficacy in a evolving market.
Company Financial ReportsStock Exchange Disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |